REPRIEVE Heart Disease Trial Enrolls 1,200 Seeks Female Participants

The REPRIEVE trial, which will test a sort of “PrEP for heart disease” among 6,500 people with HIV at sites around the world, has already enrolled 1,200 volunteers, though this month it launched its “Follow Your Heart” campaign in an effort to have more women as part of the study.

David Heitz
HIV Equal

Read the full article here.